Chris Lewis
Stock Analyst at Roth Capital
(3.07)
# 1,101
Out of 4,814 analysts
13
Total ratings
88.89%
Success rate
56.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chris Lewis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGNT Cognyte Software | Reinstates: Buy | $4 | $9.51 | -57.92% | 5 | Nov 8, 2017 | |
| IRMD IRADIMED CORPORATION | Reinstates: Buy | $16 | $51.50 | -68.93% | 3 | Oct 31, 2017 | |
| AXGN Axogen | Initiates: Buy | $15 | $15.56 | -6.81% | 1 | Mar 6, 2017 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $41.59 | - | 3 | Feb 22, 2017 | |
| IRIX IRIDEX | Initiates: Buy | $20 | $1.02 | +1,860.78% | 1 | Dec 21, 2016 |
Cognyte Software
Nov 8, 2017
Reinstates: Buy
Price Target: $4
Current: $9.51
Upside: -57.92%
IRADIMED CORPORATION
Oct 31, 2017
Reinstates: Buy
Price Target: $16
Current: $51.50
Upside: -68.93%
Axogen
Mar 6, 2017
Initiates: Buy
Price Target: $15
Current: $15.56
Upside: -6.81%
Exact Sciences
Feb 22, 2017
Upgrades: Buy
Price Target: n/a
Current: $41.59
Upside: -
IRIDEX
Dec 21, 2016
Initiates: Buy
Price Target: $20
Current: $1.02
Upside: +1,860.78%